TR200200169T2 - IL-18 inhibitörlerinin kullanımı. - Google Patents

IL-18 inhibitörlerinin kullanımı.

Info

Publication number
TR200200169T2
TR200200169T2 TR2002/00169T TR200200169T TR200200169T2 TR 200200169 T2 TR200200169 T2 TR 200200169T2 TR 2002/00169 T TR2002/00169 T TR 2002/00169T TR 200200169 T TR200200169 T TR 200200169T TR 200200169 T2 TR200200169 T2 TR 200200169T2
Authority
TR
Turkey
Prior art keywords
inhibitors
tumor metastasis
metastasis
tumor
Prior art date
Application number
TR2002/00169T
Other languages
Unknown language ( )
English (en)
Turkish (tr)
Inventor
Dinarello Charles
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of TR200200169T2 publication Critical patent/TR200200169T2/

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/00169T 1999-07-22 2000-07-17 IL-18 inhibitörlerinin kullanımı. TR200200169T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors

Publications (1)

Publication Number Publication Date
TR200200169T2 true TR200200169T2 (tr) 2002-06-21

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00169T TR200200169T2 (tr) 1999-07-22 2000-07-17 IL-18 inhibitörlerinin kullanımı.

Country Status (31)

Country Link
US (1) US7741276B2 (en, 2012)
EP (1) EP1206274B1 (en, 2012)
JP (1) JP4827352B2 (en, 2012)
KR (1) KR100682219B1 (en, 2012)
CN (1) CN1173736C (en, 2012)
AR (1) AR024907A1 (en, 2012)
AT (1) ATE363288T1 (en, 2012)
AU (1) AU782478B2 (en, 2012)
BG (1) BG65800B1 (en, 2012)
BR (1) BR0012675A (en, 2012)
CA (1) CA2380216C (en, 2012)
CY (1) CY1107932T1 (en, 2012)
CZ (1) CZ302114B6 (en, 2012)
DE (2) DE60035049T2 (en, 2012)
DK (1) DK1206274T3 (en, 2012)
EA (1) EA005419B1 (en, 2012)
EE (1) EE04838B1 (en, 2012)
ES (1) ES2186596T3 (en, 2012)
HK (1) HK1048248B (en, 2012)
HU (1) HU228780B1 (en, 2012)
IL (2) IL131047A0 (en, 2012)
MX (1) MXPA02000838A (en, 2012)
NO (1) NO329827B1 (en, 2012)
NZ (1) NZ516535A (en, 2012)
PL (1) PL202477B1 (en, 2012)
PT (1) PT1206274E (en, 2012)
SK (1) SK287522B6 (en, 2012)
TR (1) TR200200169T2 (en, 2012)
UA (1) UA73745C2 (en, 2012)
WO (1) WO2001007480A2 (en, 2012)
ZA (1) ZA200200390B (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335336B (en, 2012) * 2000-02-10 2011-01-01 Abbott Gmbh & Co Kg
EP1331943A4 (en) 2000-10-11 2005-01-26 Viron Therapeutics Inc NUCLEIC ACID MOLECULES AND POLYPEPTIDES FOR IMMUNOMODULATION
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
WO2004032837A2 (en) * 2002-10-08 2004-04-22 Ares Trading S.A. The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ES2385639T3 (es) 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
JP2025509832A (ja) 2022-03-15 2025-04-11 コンピュジェン リミテッド Il-18bpアンタゴニスト抗体、並びに癌の治療での単剤療法及び併用療法におけるそれらの使用
AU2024206448A1 (en) 2023-01-06 2025-08-21 Lassen Therapeutics, Inc. Anti-il-18bp antibodies
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Il—18bp拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE231915T1 (de) * 1992-09-02 2003-02-15 Isis Pharmaceuticals Inc Beeinflussing der zelladhäsie durch oligonukleotide
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
CA2282845A1 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
CN1173736C (zh) 2004-11-03
CY1107932T1 (el) 2013-09-04
AU5843200A (en) 2001-02-13
SK882002A3 (en) 2002-07-02
UA73745C2 (en) 2005-09-15
HUP0202107A3 (en) 2005-01-28
KR20020027493A (ko) 2002-04-13
ES2186596T1 (es) 2003-05-16
JP2003505472A (ja) 2003-02-12
ZA200200390B (en) 2003-04-30
JP4827352B2 (ja) 2011-11-30
EP1206274B1 (en) 2007-05-30
WO2001007480A2 (en) 2001-02-01
IL147675A (en) 2009-05-04
HK1048248A1 (en) 2003-03-28
EE200200032A (et) 2003-02-17
HU228780B1 (en) 2013-05-28
US20080003216A1 (en) 2008-01-03
HK1048248B (zh) 2005-04-22
BG65800B1 (bg) 2009-12-31
ES2186596T3 (es) 2007-11-16
MXPA02000838A (es) 2002-07-30
DE60035049D1 (de) 2007-07-12
WO2001007480A3 (en) 2001-05-10
ATE363288T1 (de) 2007-06-15
NO329827B1 (no) 2011-01-03
SK287522B6 (sk) 2011-01-04
CN1364086A (zh) 2002-08-14
CZ2002195A3 (cs) 2002-06-12
AU782478B2 (en) 2005-08-04
CA2380216A1 (en) 2001-02-01
BRPI0012675B8 (en, 2012) 2021-05-25
EP1206274A2 (en) 2002-05-22
KR100682219B1 (ko) 2007-02-12
NO20020153L (no) 2002-03-11
PT1206274E (pt) 2007-07-06
HUP0202107A2 (en) 2002-10-28
NO20020153D0 (no) 2002-01-11
IL131047A0 (en) 2001-01-28
DE60035049T2 (de) 2007-09-27
US7741276B2 (en) 2010-06-22
PL202477B1 (pl) 2009-06-30
CA2380216C (en) 2012-01-31
EA005419B1 (ru) 2005-02-24
NZ516535A (en) 2004-04-30
CZ302114B6 (cs) 2010-10-20
DK1206274T3 (da) 2007-08-13
BRPI0012675B1 (pt) 2001-02-01
BG106311A (en) 2002-08-30
EE04838B1 (et) 2007-06-15
BR0012675A (pt) 2002-04-09
AR024907A1 (es) 2002-10-30
PL353732A1 (en) 2003-12-01
DE1206274T1 (de) 2002-11-14
EA200200189A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
DE69925133D1 (de) Pyrrolobenzodiazepine
ATE264863T1 (de) 28-epirapaloge
TR200102711T2 (tr) Kriz halindeki başağrılarının iyileştirilmesinde kullanıma yönelik antikonvülsan türevler
IS6217A (is) Mótefnissameindir með sérvirkni fyrir alfa æxlisdrepboða í mönnum og notkun þeirra
EE200100524A (et) CYP2D6 inhibiitorite kasutamine kombineeritud ravis
UY27972A1 (es) Derivados de hidantoína
NO20025442L (no) Brachyterapi kilde
ATE237329T1 (de) Metalloprotease inhibitoren
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
NO20014243D0 (no) Dihetero-substituerte metalloprotease inhibitorer
DE59806475D1 (de) Urokinase-inhibitoren
SE9904674D0 (sv) Novel compounds
FI20010620L (fi) Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
BR0316544A (pt) Compostos calcilìticos
DE60106850D1 (de) Wälzschleifen von nichtmetallischen Zahnrädern
DE50311665D1 (de) Guanidinophenylalanin-verbindungen als urokinase-inhibitoren
ATE377586T1 (de) Tripeptidylpeptidaseinhibitoren
AU302730S (en) Bed
NO20015922L (no) Nye calpainer og anvendelse derav
UA50030A (uk) Комплексне добриво
UA32947A (uk) Горілка особлива
SE0004239D0 (sv) New use of an inhibitor
ECSP982458A (es) Aplicación oral de (+)-o- demetiltramadol como analgesico